Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Peptide Hydrogel Boosts Cancer Immunotherapies

A team at Rice University in Houston developed an injectable gel material that in lab mice slows the release of cancer immunotherapy drugs, enhancing the treatments’ effectiveness and reducing the need for repeated doses. . . . → Read More: Peptide Hydrogel Boosts Cancer Immunotherapies

3-D Biomaterial Boosts Personal Cancer Immunotherapy

A Harvard University bioengineering lab developed an injectable material designed to load up with proteins from a patient’s own tumors to induce immune reactions that fight that person’s cancer. . . . → Read More: 3-D Biomaterial Boosts Personal Cancer Immunotherapy

Start-Up Developing Blood-Brain Barrier Treatments

A medical school professor in Singapore is starting a biotechnology company to discover and develop new drugs for neurological disorders based on his research with mechanisms for crossing the blood-brain barrier. . . . → Read More: Start-Up Developing Blood-Brain Barrier Treatments

Protein Engineered to Boost Nerve Cell Imaging

Engineers and neuroscientists developed a synthetic protein that illuminates electrical activity in animal brain nerve cells, with a process using robotics to test millions of protein candidates in cells. . . . → Read More: Protein Engineered to Boost Nerve Cell Imaging

RNA Vaccine Shows Promise with Infant Viral Diseases

A vaccine using synthetic RNA, with protein instructions transcribed from one’s genetic code, is shown in tests with lab animals to protect against infections from cytomegalovirus, a virus affecting infants and transplant recipients. . . . → Read More: RNA Vaccine Shows Promise with Infant Viral Diseases

Gut Tissue From Stem Cells Simulated on Organ Chips

Researchers created working human gut tissue cells derived from stem cells, grown on plastic chips simulating intestinal diseases, as a tool for testing effectiveness and safety of treatments before given to patients. . . . → Read More: Gut Tissue From Stem Cells Simulated on Organ Chips

Open-Source Discovery Seeks Neglected Disease Drug

An international online collaboration is using an open process to discover new drug compounds to treat mycetoma, a slow-progressing inflammatory fungal disease occurring mainly in developing regions, which up to now is largely neglected. . . . → Read More: Open-Source Discovery Seeks Neglected Disease Drug

Biotech, Univ. Lab Partner on Stem Cells for Alzheimer’s

A biotechnology company specializing in stem cell therapeutics is licensing a process from Texas A&M University to produce exosomes — cellular delivery packages — from adult stem cells as possible therapies for Alzheimer’s disease. . . . → Read More: Biotech, Univ. Lab Partner on Stem Cells for Alzheimer’s

Texas Vaccine Center Expanding R&D

A vaccine research center in Galveston, Texas is expanding its operations to add more basic and preclinical studies that lead to clinical trials resulting in more preventive and therapeutic vaccines. . . . → Read More: Texas Vaccine Center Expanding R&D

Overlooked Drugs Show Promise Against Superbugs

A class of antibiotics first discovered in the 1970s, but passed by as new drugs came on the market, are getting a second look as the need intensifies for better weapons to treat infections resistant to most antibiotics. . . . → Read More: Overlooked Drugs Show Promise Against Superbugs